hh.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Overcoming hospital resistance in an international innovation co-creation
Global Opportunities Commercialization, Melbourne, Australia; Ku Leuven, Leuven, Belgium.
University Oslomet, Oslo, Norway; Oulu Business School, Oulu, Finland.
Oulu Business School, Oulu, Finland.
Halmstad University, School of Business, Innovation and Sustainability.ORCID iD: 0000-0002-8194-2053
2023 (English)In: Technological forecasting & social change, ISSN 0040-1625, E-ISSN 1873-5509, Vol. 187, article id 122195Article in journal (Refereed) Published
Abstract [en]

The health sector is very specific and difficult market for firms to access and deal with. The main reasons for this is that the healthcare systems are in continuous change, the co-creation processes in hospitals are complicated involving many different actors which also affects on firms commercialization and internationalization approaches. However, there is a growing demand of health services and the sector is growing also due to the COVID situation, that has been dramatically speeding up the digitalization of the healthcare services in the hospital settings. Approaching international hospital markets is, however, challenging for the start-up companies. On their journey they are facing a resistance, that they have to overcome in many different ways. The aim of this paper is to increase understanding how a start-up can overcome hospital resistance in an international innovation co-creation process. The results of are based on in depth case study in which the data collection was done over the four years of data gathering. The paper highlights how start-up companies can overcome the resistance in the international innovation co-creation in the hospital markets. It shows the importance of different activities, actors, capabilities and international activities in different phases of the international innovation co-creation journey. © 2022

Place, publisher, year, edition, pages
New York: Elsevier, 2023. Vol. 187, article id 122195
Keywords [en]
Co-creation, Entrepreneur, Innovation, Resistance, SME
National Category
Business Administration
Identifiers
URN: urn:nbn:se:hh:diva-49089DOI: 10.1016/j.techfore.2022.122195ISI: 000969505700020Scopus ID: 2-s2.0-85143983382OAI: oai:DiVA.org:hh-49089DiVA, id: diva2:1724984
Available from: 2023-01-09 Created: 2023-01-09 Last updated: 2023-08-21Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textScopus

Authority records

Andersson, Svante

Search in DiVA

By author/editor
Andersson, Svante
By organisation
School of Business, Innovation and Sustainability
In the same journal
Technological forecasting & social change
Business Administration

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 133 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf